BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

631 related articles for article (PubMed ID: 15125396)

  • 21. [Paraneoplastic cerebellar degeneration].
    Sakai K
    Brain Nerve; 2010 Apr; 62(4):357-64. PubMed ID: 20420175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paraneoplastic neurological syndrome: patient with anti-Yo antibody and breast cancer: a case report.
    Dorn C; Knobloch C; Kupka M; Morakkabati-Spitz N; Schmolling J
    Arch Gynecol Obstet; 2003 Nov; 269(1):62-5. PubMed ID: 14605824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Paraneoplastic cerebellar degeneration: case report of a patient with breast carcinoma].
    Huober J; Niedermaier N; Drlicek M; Kaufmann M; Hacke W; Bastert G
    Geburtshilfe Frauenheilkd; 1996 Apr; 56(4):214-6. PubMed ID: 8682288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deterioration of anti-Yo-associated paraneoplastic cerebellar degeneration.
    Finsterer J; Voigtländer T; Grisold W
    J Neurol Sci; 2011 Sep; 308(1-2):139-41. PubMed ID: 21762925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paraneoplastic cerebellar degeneration in a woman with ovarian cancer.
    Santillan A; Bristow RE
    Nat Clin Pract Oncol; 2006 Feb; 3(2):108-12; quiz 1 p following 112. PubMed ID: 16462852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antineuronal autoantibodies in paraneoplastic cerebellar degeneration associated with adenocarcinoma of the prostate.
    Greenlee JE; Clawson SA; Hill KE; Dechet CB; Carlson NG
    J Neurol Sci; 2010 Apr; 291(1-2):74-8. PubMed ID: 20089262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neurologic paraneoplastic syndromes and anti-neuronal antibodies].
    Mygland A
    Tidsskr Nor Laegeforen; 1996 Jan; 116(3):361-5. PubMed ID: 8638263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-Yo positive paraneoplastic cerebellar degeneration in the setting of cholangiocarcinoma.
    Bruhnding A; Notch D; Beard A
    J Clin Neurosci; 2017 Feb; 36():71-72. PubMed ID: 27816258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Paraneoplastic cerebellar degeneration].
    Chabriat H; Chen QM; Poisson M; Delattre JY
    Rev Neurol (Paris); 1994; 150(2):105-14. PubMed ID: 7863150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-Yo antibody uptake and interaction with its intracellular target antigen causes Purkinje cell death in rat cerebellar slice cultures: a possible mechanism for paraneoplastic cerebellar degeneration in humans with gynecological or breast cancers.
    Greenlee JE; Clawson SA; Hill KE; Wood B; Clardy SL; Tsunoda I; Carlson NG
    PLoS One; 2015; 10(4):e0123446. PubMed ID: 25885452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoimmune paraneoplastic cerebellar degeneration in ovarian carcinoma patients treated with plasmapheresis and immunoglobulin. A case report.
    David YB; Warner E; Levitan M; Sutton DM; Malkin MG; Dalmau JO
    Cancer; 1996 Nov; 78(10):2153-6. PubMed ID: 8918408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spectrum of paraneoplastic neurologic disorders in women with breast and gynecologic cancer.
    Rojas-Marcos I; Rousseau A; Keime-Guibert F; Reñé R; Cartalat-Carel S; Delattre JY; Graus F
    Medicine (Baltimore); 2003 May; 82(3):216-23. PubMed ID: 12792307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Autoimmunity and paraneoplastic neurologic syndromes].
    Delattre JY; Davila L; Vega F; Poisson M
    Rev Neurol (Paris); 1991; 147(8-9):549-56. PubMed ID: 1962063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-Ri-associated paraneoplastic cerebellar degeneration without opsoclonus in a patient with a neuroendocrine carcinoma of the stomach.
    Kikuchi H; Yamada T; Okayama A; Hara H; Taniwaki T; Shigeto H; Sasaki M; Iwaki T; Kira J
    Fukuoka Igaku Zasshi; 2000 Apr; 91(4):104-9. PubMed ID: 10826224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cdr2, a target antigen of naturally occuring human tumor immunity, is widely expressed in gynecological tumors.
    Darnell JC; Albert ML; Darnell RB
    Cancer Res; 2000 Apr; 60(8):2136-9. PubMed ID: 10786675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphological and immunohistochemical characterization of paraneoplastic cerebellar degeneration associated with Yo antibodies.
    Storstein A; Krossnes BK; Vedeler CA
    Acta Neurol Scand; 2009 Jul; 120(1):64-7. PubMed ID: 19486326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-Yo antibody associated with occult fallopian tube carcinoma.
    Selby KJ; Warner J; Klempner S; Konstantinopoulos PA; Hecht JL
    Int J Gynecol Pathol; 2011 Nov; 30(6):536-8. PubMed ID: 21979588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Paraneoplastic cerebellar degeneration and Lambert-Eaton myasthenic syndrome associated with anti P/Q-type voltage-gated calcium channel antibody in a patient with primary double lung cancer].
    Iwanami M; Odaka M; Nakamura T; Hirata K
    Brain Nerve; 2009 Sep; 61(9):1083-7. PubMed ID: 19803409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A case of small cell carcinoma of the lung associated with paraneoplastic cerebellar degeneration and Lambert-Eaton myasthenic syndrome].
    Seki N; Mitsui J; Hoshino M; Akishiro M; Ugawa Y; Goto J; Tsuji S
    No To Shinkei; 2006 Jan; 58(1):68-73. PubMed ID: 16482925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ovarian cancer and late onset paraneoplastic cerebellar degeneration.
    Goldstein BH; Birk CL; Van Houten M; Veve R; Brown JV; Rettenmaier MA; Micha JP
    Arch Gynecol Obstet; 2009 Jul; 280(1):99-101. PubMed ID: 18987868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.